Content Spotlight
Podcast: Sustainability equals efficiency, says eXmoor
eXmoor Pharma discusses the steps taken to build a more sustainable facility, the importance of its design, and calls for industry to share advice and initiatives.
Latest News
thumbnail
Therapeutic ClassReport predicts 11.6% growth for single-use tech
Report predicts 11.6% growth for single-use tech
Single use technologies (SUTs) market to grow from $6.5 billion in 2024 to $11.2 billion by 2029, says report.
Deal-Making
Opentrons workstation and automation-enabled assays will deliver increased consistency and higher throughput, MilliporeSigma said.
Deal-Making
Axovia teams with Viralgen to manufacture BBS gene therapyAxovia teams with Viralgen to manufacture BBS gene therapy
The companies will rely on AskBio’s Pro10 manufacturing platform to target retinal degeneration.
Facilities & Capacity
Gates' impact on global health and biologics manufacturing to increaseGates' impact on global health and biologics manufacturing to increase
Decisions from the Trump administration could make billionaire Bill Gates the biggest player in global health, with potential downstream impacts on manufacturing.
Therapeutic Class
True CRDMO offering to drive differentiated growth for Thermo, analystTrue CRDMO offering to drive differentiated growth for Thermo, analyst
Jefferies believes formally bringing together its acquired CRO and CMO businesses will be an “overlooked” driver of differentiated performance for Thermo Fisher.
Global Markets
Gates' impact on global health and biologics manufacturing to increaseGates' impact on global health and biologics manufacturing to increase
Decisions from the Trump administration could make billionaire Bill Gates the biggest player in global health, with potential downstream impacts on manufacturing.
Deal-Making
Samsung Bio lands $1.4bn contract with undisclosed EU clientSamsung Bio lands $1.4bn contract with undisclosed EU client
Contract development and manufacturing organization (CDMO) Samsung Biologics will provide manufacturing services for the client in what it calls its ‘largest ever contract’.
Regulations
Gates' impact on global health and biologics manufacturing to increaseGates' impact on global health and biologics manufacturing to increase
Decisions from the Trump administration could make billionaire Bill Gates the biggest player in global health, with potential downstream impacts on manufacturing.
Facilities & Capacity
FDA cites contamination concerns in warning to Sanofi MA plantFDA cites contamination concerns in warning to Sanofi MA plant
Approximately 20% of bioreactor runs over 30 months were rejected due to contamination issues at Sanofi’s Framingham biologics facility, according to the US FDA.
Therapeutic Class
In the race to stop mpox, GeoVax prepares for a marathonIn the race to stop mpox, GeoVax prepares for a marathon
Vaccine maker GeoVax is readying one of two modified vaccinia Ankara (MVA) candidates for Phase III clinical trials before the end of 2025.
Therapeutic Class
Single use technologies (SUTs) market to grow from $6.5 billion in 2024 to $11.2 billion by 2029, says report.
Upstream & Downstream Processing
In the race to stop mpox, GeoVax prepares for a marathonIn the race to stop mpox, GeoVax prepares for a marathon
Vaccine maker GeoVax is readying one of two modified vaccinia Ankara (MVA) candidates for Phase III clinical trials before the end of 2025.
Global Markets
Gates' impact on global health and biologics manufacturing to increaseGates' impact on global health and biologics manufacturing to increase
Decisions from the Trump administration could make billionaire Bill Gates the biggest player in global health, with potential downstream impacts on manufacturing.